Teriflunomide is not recommended for treating adults with active relapsing remitting multiple sclerosis (normally defined as 2 clinically significant relapses in the previous 2 years), if they have highly active or rapidly evolving severe relapsing remitting multiple sclerosis Do not do January 2014 Unclassified